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Structures of the L I Domain and Its Complex
with ICAM-1 Reveal a Shape-Shifting
Pathway for Integrin Regulation
members of the Ig superfamily (IgSF) of which ICAM-1
is the most biologically important (Dustin and Springer,
1999). ICAM-1 is highly inducible on antigen-presenting
cells and endothelium by cytokines in inflammation.
Although the extracellular domains of L and 2 are
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each large and structurally complex, the ligand binding1The Center for Blood Research
site is contained solely within the 180 residue insertedDepartment of Pathology
(I) domain of L (Shimaoka et al., 2001, 2002). The IDepartment of Anesthesia
domain is important in ligand binding in the 9 of 18Department of Pediatrics
integrin  subunits in which it is present. Crystal struc-2 Dana-Farber Cancer Institute
tures of integrin I domains reveal a dinucleotide bindingDepartment of Pediatrics
or Rossmann fold, with a central hydrophobic  sheetDepartment of Medicine
surrounded by seven amphipathic  helices (Lee et al.,Department of Biological Chemistry
1995b; Shimaoka et al., 2002). A Mg2 ion is coordinatedDepartment of Molecular Pharmacology
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Integrins trigger “outside-in” signals in response to3 Biosciences Division
ligand binding (Giancotti and Ruoslahti, 1999; SchwartzArgonne National Laboratory
and Ginsberg, 2002). In B and T cell responses, L2Argonne, Illinois 60439
augments proliferation and protects against apoptosis
(Koopman et al., 1994; Van Seventer et al., 1990). Ligand
binding induces significant structural rearrangements inSummary
the I domain of the integrin 2 subunit, as seen in a
complex with a collagen-like peptide (Emsley et al.,The structure of the I domain of integrin L2 bound
2000). Compared to the unliganded “closed” conforma-to the Ig superfamily ligand ICAM-1 reveals the open
tion of the 2 I domain, the liganded “open” conforma-ligand binding conformation and the first example of
tion exhibits a large 10 A˚ movement of the C-terminalan integrin-IgSF interface. The I domain Mg2 directly
 helix down the side of the domain, and a rearrange-coordinates Glu-34 of ICAM-1, and a dramatic swing of
ment in metal coordination at the MIDAS. The metal ionI domain residue Glu-241 enables a critical salt bridge.
is central in the binding site and directly coordinates aLiganded and unliganded structures for both high- and
Glu residue in the ligand. A similar conformationalintermediate-affinity mutant I domains reveal that li-
change has been observed in the M I domain; however,gand binding can induce conformational change in the
in this case it is induced by a ligand-like contact of theL I domain and that allosteric signals can convert the
metal in the MIDAS with a Glu residue of a neighboringclosed conformation to intermediate or open confor-
I domain in the crystal lattice (Lee et al., 1995b). Bymations without ligand binding. Pulling down on the
contrast, multiple L I domain structures have consis-C-terminal 7 helix with introduced disulfide bonds
tently revealed the unliganded, closed conformationratchets the 6-7 loop into three different positions
(Kallen et al., 1999; Legge et al., 2000; Qu and Leahy,in the closed, intermediate, and open conformations,
1995, 1996).with a progressive increase in affinity.
In the absence of activation, L2 has low affinity for
ligand (Dustin and Springer, 1989; Lollo et al., 1993). In
Introduction
inside-out signaling by integrins, signals received by
other receptors activate intracellular signaling pathways
Integrins are a family of noncovalently associated,  that impinge on integrin cytoplasmic domains and make
heterodimeric transmembrane molecules that mediate the extracellular domain competent for ligand binding
cell-cell and cell-extracellular matrix adhesion. Lympho- on a timescale of less than 1 s (Hughes and Pfaff, 1998;
cyte function-associated antigen-1 (LFA-1, L2) is an Lollo et al., 1993; Shimaoka et al., 2002). This unique
integrin that is critically important in antigen-specific property enables leukocytes to rapidly respond to sig-
responses and homing by lymphocytes and together nals in the environment, such as foreign antigen or che-
with other 2 integrins in diapedesis by monocytes and moattractants, to activate adhesion and direct cell mi-
neutrophils at inflammatory sites (Gahmberg et al., 1997; gration. A disulfide bond has been introduced into the
Larson and Springer, 1990; Shimaoka et al., 2002). L2 L I domain to stabilize the predicted open conformation
recognizes intercellular adhesion molecules (ICAMs), and was found to increase the affinity for ICAM-1 by
10,000-fold (Shimaoka et al., 2001). This strongly sup-
*Correspondence: springer@cbr.med.harvard.edu (T.A.S.), jwang@ ports the idea that conformation regulates affinity; how-
red.dfci.harvard.edu (J.-H.W.) ever, whether the open conformation would be stable
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in the absence of bound ligand has not been established5 Present address: Institute of Biophysics, Academia Sinica, Beijing,
because all open I domain structures determined to date100101, P. R. China.
are ligand bound (Emsley et al., 2000; Lee et al., 1995b).6 Present address: Department of Microbiology and Immunology,
Wonkwang University Medical School, Chonbuk 570-749, Korea. Two activation states have been defined functionally for
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Table 1. L I Domain Design and Binding to ICAM-1
Open Closed
I Domain C - C Distance (A˚) kon (M1s1  103) koff (s1) KD (M) Class
K287C/K294C 3.8 9.1 115  7 0.014  0.001 0.15  0.016 High
E284C/E301C 7.0 12.5 105  3 0.045  0.006 0.36  0.04 High
L161C/F299C 8.1 11.4 133  10 0.43  0.07 3.0  0.44 Inter.
K160C/F299C 7.8 8.0 103  15 0.77  0.07 8.4  2.4 Inter.
L161C/T300C 13.0 14.9 89  12 0.76  0.07 9.4  2.4 Inter.
K160C/T300C 12.8 10.9 3.4  0.9 1.2  0.08 450  210 Low
L289C/K294C 8.0 3.9 2.3  0.3 3.6  0.34 1600  170 Low
Wild-type N/A N/A 3.1  0.1 4.6  0.36 1500  200 Low
The distances between wild-type residue C atoms replaced with cysteine in mutants were measured in the open model (Shimaoka et al.,
2001) or closed L structure (1ZON) (Qu and Leahy, 1996).
The interaction of I domains with immobilized ICAM-1 in the presence of Mg2 was monitored with surface plasmon resonance. kon and koff
were obtained by curve fitting using a 1:1 binding model. KD was calculated by Scatchard plot using binding at steady state.
Structures of the underlined mutants K287C/K294C and L161C/F299C are determined here. N/A, not applicable.
L2 on cells activated by differing stimuli. Both states residue in the C-terminal 7 helix. None of the new muta-
tions had C-C distances that were optimal for disul-are competent for cell adhesion, but high-affinity soluble
ligand binding is only detectable for one of these states fide formation (3.3 to 4.4 A˚); however, one or both resi-
dues of each pair were in an  helix or loop where(Constantin et al., 2000; Stewart et al., 1996; van Kooyk
et al., 1999). However, the concept that I domains might backbone movements should be allowable that would
permit disulfide formation.exist in intermediate- as well as high-affinity states (Shi-
maoka et al., 2001) has not been tested by attempting Affinity and kinetic measurements using surface plas-
mon resonance (Shimaoka et al., 2001) showed that theto mutationally stabilize such states or define their
structure. mutant L I domains fell into three classes (Table 1).
Two mutants with the closest C-C distances in theBecause of the key role of the interaction between
LFA-1 and ICAM-1 in immune responses, defining its predicted open conformation, and the greatest increase
in C-C distances in the closed conformation, boundstructural basis is of great interest. Furthermore, devel-
opment of pharmaceutical antagonists of this interac- to ICAM-1 with high affinity (KD of 150 to 360 nM). Three
mutants, which also had C-C atoms that were closertion is of great importance for treatment of autoimmune
disease (Giblin and Kelly, 2001; Gottlieb et al., 2000). in the predicted open than the closed conformation,
bound ICAM-1 with intermediate affinity (KD of 3 to 9Crystal structures have been determined for IgSF mole-
cules recognized by integrins, i.e., ICAM-1 (Bella et al., M). Two mutants which had C-C atoms that were
closer in the closed than the predicted open conforma-1998; Casasnovas et al., 1998), ICAM-2 (Casasnovas et
al., 1997), VCAM-1, and MAdCAM-1 (Wang and Springer, tion had low affinity (KD of 0.5 to 1.6 mM), similar to the
KD of 1.5 mM of the wild-type I domain. DTT reduction1998), but not for IgSF complexes with integrins. Here,
the crystal structure of the I domain:ICAM-1 complex of the disulfides of the mutants of the high- and interme-
diate-affinity classes reduced their affinity to wild-typereveals an atomic view of an integrin-IgSF ligand inter-
face for the first time. Furthermore, multiple I domain levels, and EDTA abolished binding, showing that the
interactions were Mg2 dependent (data not shown). Allstructures reveal an intermediate state in the shape-
shifting pathway and show that the I domain can be of the L I domain disulfide bond mutants we have made
are described here. It is interesting that the affinities ofstabilized in the open conformation in the absence of
bound ligand. the mutants cluster into three groups of high, intermedi-
ate, and low affinity, because this clustering is consis-
tent with the existence of three distinct conformationalResults and Discussion
states, as shown below. The kinetics of the mutants also
cluster. Interestingly, the kon of the intermediate- andDesigned L I Domains
high-affinity mutants are increased by a similar amountPreviously, L residues 289 and 294 or residues 287
(Table 1).and 294 were mutated to cysteine to stabilize the closed,
or the predicted open, conformations of the I domain,
respectively (Table 1; Shimaoka et al., 2001). We made Four Intermediate- and High-Affinity L I Domain
Crystal Structuresfour further pairs of cysteine substitutions where the
C-C distances were predicted to be closer in the Crystal structures were determined for representative
intermediate-affinity (L161C/F299C) and high-affinityopen than closed conformation and hence should form
disulfides that stabilized the open conformation, and (K287C/K294C) L I domain mutants (Table 2). Each was
determined in two forms. Intermediate-affinity I domainwe made one pair of cysteine substitutions where the
C-C distances were more favorable for the closed structures were determined in the unliganded state
(1.3 A˚ resolution) or in complex with ICAM-1 (3.3 A˚).conformation (Table 1). All cysteine substitutions were
distant from the MIDAS and ligand binding surface so High-affinity I domain structures were determined in the
unliganded state (2.5 A˚) or in the “pseudo-liganded”that direct involvement of the mutated residues in ligand
binding could be ruled out. All mutations included one state (2.0 A˚), i.e., with a ligand-mimetic lattice contact
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Table 2. Statistics of X-Ray Diffraction Data Collection and Structure Refinement
Intermediate-Affinity I Domain High-Affinity I Domain
Unliganded  ICAM-1 Unliganded Pseudo-liganded
Space group P212121 P1 C2221 P41212
Unit cell
a, b, c (A˚) 40.4, 57.4, 66.9 46.6, 62.9, 81.5 61.9, 121.3, 54.1 35.6, 35.6, 269.6
, ,  (	) 90, 90, 90 95.4, 106.7, 90 90, 90, 90 90, 90, 90
Resolution (A˚) 50–1.3 50–3.3 50–2.5 50–2.0
Number of reflections (total/unique) 197,616/35,329 23,330/12,338 41,352/7,271 57,584/10,569
L residues 128–306 128–306 128–300 128–300
Number of protein/ hetero-atoms 1427/329 5680/172 1388/31 1380/91
Completeness (%) 90.2/47.0a 92.3/70.7a 94.2/60.4a 82.1/67.5a
I/
(I) 17.8/2.4a 7.7/1.5a 8.4/2.0a 12.6/3.5a
Rmerge (%)b 8.8/35.2a 9.4/41.2a 18.4/41.3a 9.4/38.1a
Rmsd bond lengths 0.012 A˚ 0.016 A˚ 0.005 A˚ 0.006 A˚
Rmsd bond angles 2.4	 1.7	 1.3	 1.3	
Rworkc 15.6% 26.4% 25.0% 21.3%
Rfreed 20.0% 31.3% 28.7% 26.5%
Average B factor 15.9 A˚2 67.3 A˚2 34.7 A˚2 23.7 A˚2
Ramachandran plot (core/disallowed)e 91.6%/0% 72.7%/0% 80.5%/0% 90.6%/0%
PDB code 1MJN 1MQ8 1MQA 1MQ9
a The second of each pair of numbers corresponds to the last resolution shell.
b Rmerge  hi|Ii(h )  I(h )|/hi Ii(h ), where Ii(h ) and I(h ) are the ith and mean measurement of the intensity of reflection h.
c Rwork  h||Fobs (h )|  |Fcalc (h )||/h|Fobs (h )|, where Fobs (h ) and Fcalc (h ) are the observed and calculated structure factors, respectively. No I/

cutoff was applied.
dRfree is the R value obtained for a test set of reflections consisting of a randomly selected 10% (for the unliganded intermediate-affinity,
unliganded and pseudo-liganded high-affinity structures) or 5% (the I domain-ICAM-1 complex structure) subset of the data set excluded
from refinement.
e Residues in core (most favorable) and disallowed regions of the Ramachandran plot as reported by Procheck (Laskowski et al., 1993).
at the MIDAS. All structures were solved using molecular 2B, bottom) protrudes and inserts its side chain into a
replacement (Table 2). shallow cleft between Met-64 and Pro-36 on ICAM-1
(Figure 2B, top).
The metal coordination bond between the Mg2 andStructure of an Integrin—IgSF Complex
Glu-34 is surrounded on the I domain by a ring of hy-A fragment of ICAM-1 containing IgSF domains 1–3 (resi-
drophobic residues (Leu-204, Leu-205, and Met-140)dues 1–291) crystallized in complex with the intermedi-
and the aliphatic portion of Thr-243 (Figure 2A, bottom).ate-affinity L I domain (Figure 1A). There is no meaning-
All interacting residues are contributed by the 1-1,ful density for IgSF domain 3 of ICAM-1, which appears
3-4, and 4-5 loops, which also bear metal-coordi-to be mobile within the crystal lattice. Domains 1 and 2
nating residues and form the MIDAS (Figures 2C andof ICAM-1 have an extended orientation with an angle
3A). The ring of hydrophobic residues on the I domainbetween domains 1 and 2 within the range previously
is in contact with a similar ring of hydrophobic residuesobserved (Bella et al., 1998; Casasnovas et al., 1998).
on ICAM-1 that surround Glu-34: Pro-36, Tyr-66, Met-There are no significant rearrangements in ICAM-1 asso-
64, and the aliphatic portions of Gln-62 and Gln-73 (Fig-ciated with binding to the L I domain.
ure 2A, top). The surrounding nonpolar environment willA total of 1250 A˚2 of solvent-accessible surface is
strengthen the Coulombic interaction between the Glu-buried in the I domain:ICAM-1 contact. This is a small
34 of ICAM-1 and Mg2 of the MIDAS.interface for a protein:protein interaction (1600 400 A˚2 )
Surrounding the hydrophobic ring are polar interac-(Conte et al., 1999). A shallow groove bearing the MIDAS
tions involving hydrogen bonds and salt bridges thaton the “top” face of the I domain binds to the side of
appear to orient ICAM-1 for optimal contact with the Idomain 1 of ICAM-1, making no contacts with the flexible
domain and further strengthen their interaction. Manyloops at the N-terminal end of domain 1 (Casasnovas
of the hydrogen bonds are backbone to side chain. Hy-et al., 1998) or with domain 2 (Figure 1A). The contacting
drogen bonding residues include Thr-35, Pro-36, Asn-ICAM-1  strands lie parallel to the groove (Figure 1A).
68 in ICAM-1, and Gln-143, Thr-243, and His-264 in theThese are the F and C  strands on the edge of one
I domain (Figure 2C). The overall electrostatic surface ofsheet and the D  strand on the edge of the other sheet.
the contact area displays good charge complementarityGlu-34 at the end of  strand C of ICAM-1 forms a direct
(Figure 2B). A salt bridge between Glu-241 of the I do-coordination through its acidic side chain to the Mg2
main and Lys-39 of ICAM-1, both of which are crucialion held in the I domain MIDAS, which is in the open
for ligand binding (Edwards et al., 1998; Fisher et al.,conformation. Glu-34 sits precisely in the middle of the
1997), also facilitates positioning of ICAM-1 and the Icontact surface on ICAM-1 (magenta surface, Figure 2A,
domain for optimal interaction (Figures 2B and 2C). Thistop), as does the Mg2 ion on the I domain (magenta,
contact is only possible because of a dramatic reorienta-Figure 2A, bottom). The contact surface is relatively flat,
with the exception that Met-140 on the I domain (Figure tion of the Glu-241 side chain upon conversion of the
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Figure 1. Two L I Domains Bound to an
ICAM-1 Dimer
(A) Ribbon diagram of one monomeric unit of
the intermediate-affinity L I domain (gold)
complex with ICAM-1 domains 1-2 (cyan).
The Mg2 ion is shown as a magenta sphere.
I domain MIDAS and ICAM-1 Glu-34 side
chains are shown as ball-and-stick with red
oxygen atoms. The interacting  strands C,
D, and F of ICAM-1 are labeled. N-acetyl glu-
cosamine residues of ICAM-1 are shown with
silver bonds.
(B) The two ICAM-1-I domain complexes in
the crystallographic asymmetric unit are
shown with the I domains colored gold and
the two ICAM-1 molecules colored cyan and
green. The 2-fold axis between the ICAM-1
molecules is in the vertical direction, normal
to the predicted membrane plane. Positions
of the magnesium ions (magenta spheres)
and Glu-34 of ICAM-1 (CPK) are shown for
reference. The ICAM-1 Val-51 residues at the
center of the ICAM-1 dimer interface are
shown as gray CPK models.
(C) A view of domains 1 of the ICAM-1 dimer
(cyan and green), rotated about 90	 from the
view in (B), with domain 1 of the uncomplexed
ICAM-1 molecule A dimer (Casasnovas et al.,
1998) superimposed using domain 1 of one
of the ICAM-1 molecules (black), whereas the
other one is colored gray. Figures 1–5 are
prepared with programs GLR (provided by
L. Esser), Molscript (Kraulis, 1991), Bobscript
(Esnouf, 1997), Raster3D (Merritt and Mur-
phy, 1994), GRASP (Nicholls et al., 1991), and
Povray (The Povray Team, http://www.
povray.org).
L I domain to the open conformation (Figure 4A), as main complex appears ideal for physiologic binding of
two L2 heterodimers to a cell surface ICAM-1 dimer.described below.
Previous mutational studies define the relative impor- The bottoms of the two I domains bearing the connec-
tions to other integrin domains point in opposite direc-tance of the interactions revealed in the interface (Ed-
wards et al., 1998; Fisher et al., 1997; Huang and tions and away from the connection of ICAM-1 domain
2 to domains 3–5 (Figure 1B). Orienting each half of theSpringer, 1995; Kamata et al., 1995; Staunton et al.,
1990). Glu-34 of ICAM-1 and the residues that coordi- dimer similarly in the interface between two adherent
cells places the dimer symmetry axis normal to the twonate with the Mg2 in the MIDAS of the I domain have
long been identified as crucial. The ICAM-1 contact resi- cell membranes (Figure 1B). Thus, our structure pro-
vides the first glimpse of the orientation between twodues Lys-39, Met-64, Tyr-66, Asn-68, and Gln-73 were
also previously recognized as important in mutational cells of LFA-1 and ICAM-1 in the immunological synapse
(Grakoui et al., 1999). Our structure also provides the firststudies, as were the I domain contact residues Met-140,
Glu-146, Leu-205, Glu-241, Thr-243, and Ser-243. glimpse of a dimeric integrin-ligand interaction. Since
essentially all integrin ligands are either dimeric (in solu-
tion) or multimeric (on cell surfaces and the extracellular
A Dimeric Integrin-Ligand Complex matrix), dimeric interactions of integrins with ligands are
The crystal asymmetric unit contains two ICAM-1:I do- likely to be of broad significance.
main complexes that are related by 2-fold noncrystallo-
graphic symmetry (Figure 1B). The two ICAM-1 mole-
cules dimerize at a hydrophobic interface on the BED Ligand-Induced Conformational Change in the I
Domain: Outside-In Signalingsheet of domain 1. A total of 1100 A˚2 of solvent-accessi-
ble surface is buried. Dimerization at the same hy- Comparison between the unliganded and liganded inter-
mediate affinity I domain structures reveals the criticaldrophobic interface centered on Val-51 was seen in
crystals of ICAM-1 domains 1-2 (Casasnovas et al., rearrangements in the ligand binding site that are in-
duced by binding to ICAM-1 (see Supplemental Movie1998) and was suggested to mediate physiologic dimer-
ization on the cell surface. Comparison of ICAM-1 di- S1 at http://www.cell.com/cgi/content/full/112/1/99/
DC1). The MIDAS of the unliganded intermediate-affinitymers shows some flexibility at the dimer interface (Fig-
ure 1C). I domain is in the closed conformation (Figure 3D), with
a disposition of coordinating residues and loops identi-The spatial arrangement of the dimeric ICAM-1:I do-
Recognition by an Integrin I Domain of ICAM-1
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Figure 2. The Interface between the L I Domain and ICAM-1
(A) Residues in the I domain:ICAM-1 interface in an open-book representation of the protein surface with the book folded open horizontally,
with ICAM-1 above and the I domain below. Interacting residues are colored green and labeled, except for Glu-34 in ICAM-1 and the MIDAS
Mg2 ion in ICAM-1, which are magenta and unlabeled.
(B) The electrostatic surface of the complex in the same open-book representation. The color scale for the charge distribution extends
from 10 kT/e (red) to 10 kT/e (blue) calculated using GRASP (Nicholls et al., 1991). The position of bulges in the interface are marked
by arrows, as are the salt-bridged residues Lys-39 in ICAM-1 and Glu-241 in the I domain and Glu-34 in ICAM-1 and the Mg2 ion in the I
domain.
(C) Stereo view of interface details with ICAM-1 in cyan and I domain in gold. The view is about the same as in Figure 1A. The metal ion,
oxygens, and nitrogens are represented as magenta, red, and blue spheres, respectively. Metal coordination and hydrogen bonds are
represented by solid black lines and gray dotted lines, respectively. Contacting residues are shown as ball-and-stick models. For clarity,
MIDAS residues are omitted.
cal to that of the wild-type L I domain (Figure 3E). residue Asp-239 (Figure 4A). The loss of direct metal
coordination to Asp-239 not only increases the electro-In the open conformation of the MIDAS stabilized by
ICAM-1, the direct coordination of I domain residue Asp- philicity of the metal for Glu-34 of ICAM-1, but the metal
also moves markedly closer to Glu-34 (Figure 4A). The239 to the metal is replaced by an indirect coordination
mediated by a water molecule, and the metal moves 2 A˚ movement of Ser-141 enables it to make many con-
tacts with the Glu-34 side chain of ICAM-1 and is associ-2 A˚ toward Thr-206, forming a direct coordination to it
(Figure 3A). The change in coordination is linked to a ated with a 2.5 A˚ backbone movement at I domain resi-
due Gln-143 in the 1-l loop, which brings its side chainmovement in the portion of the 1-l loop bearing MI-
DAS residue Ser-141 and the 4-5 loop bearing MIDAS into position to hydrogen bond with the backbone of
Cell
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Figure 3. MIDAS Structures
Structures are from the I domain:ICAM-1
complex (A), the pseudo-liganded high-affin-
ity I domain (B), the unliganded high-affinity
I domain (C), the unliganded intermediate-
affinity I domain (D), and the wild-type I do-
main (E) (1LFA) (Qu and Leahy, 1996). The
keys to the color scheme are shown below,
with the ICAM-1 or ligand mimetic molecule
colored cyan in (A) and (B). The metal ions
are colored blue, water molecule and ligating
side chain oxygen atoms are colored red, and
the chloride ion from the wild-type I domain
structure is colored orange. The MIDAS resi-
dues and Glu-34 from ICAM-1 in (A) and Glu-
272 from a lattice mate I domain in (B) are
shown as ball-and-stick models. Metal coor-
dination and hydrogen bonds are repre-
sented by solid black lines and gray dotted
lines, respectively.
Pro-36 of ICAM-1 (Figure 2C). The change in coordina- C-terminal region of the L I domain (Huth et al., 2000).
The changes in the 1-1 and 4-5 MIDAS loops andtion of Asp-239 is associated with a dramatic re-
arrangement in the I domain 4-5 loop bearing this the inward rigid body movement of the 1 helix, which
“squeezes” the hydrophobic core of the domain, areresidue (Figure 4A). The loop now bends at Gly-240 away
from instead of toward the Mg2, with a 4 A˚ change in essentially identical to those observed in the transition
from the closed to open conformation of the 2 andCposition and a backbone flip of Gly-240. The resulting
100	 rotation in the side chain of Glu-241 (Figure 4A) M I domains (Emsley et al., 2000; Lee et al., 1995a).
However, in the absence of ligand binding, the 6-7brings it into position to form the crucial salt bridge to
the side chain of Lys-39 in ICAM-1 (Figure 2C). loop in the intermediate-affinity I domain is already in a
conformation that is intermediate between its open andThe movement of key MIDAS and ligand binding resi-
dues in the 1-1 loop “pulls” the entire 1 helix toward closed conformations (see below). Upon ligand binding,
some readjustments occur in this loop and in 6 andthe center of the domain and is linked to key re-
arrangements in the hydrophobic core of the I domain 7, but the6-7 loop does not assume the open confor-
mation. This appears to be a consequence of constraints(Figure 4A). The side chain of Leu-142 in the 1-1 loop
is in contact with Asp-239 and helps “push” it out of imposed by the Cys-161-Cys-299 disulfide bond. The
electron density is poorest in the complex structuredirect coordination with Mg2 and induce the move-
ments in the 4-5 loop at Gly-240 and Glu-241. The nearby this disulfide and in 6 and 7, suggesting struc-
tural strain, whereas the density is excellent in all regionsside chain of Phe-265 in the 5-6 loop swings away
from the 4-5 loop and toward the 6-7 loop to make of the uncomplexed intermediate L I domain.
The interaction between LFA-1 and ICAM-1, de-way for these changes. Previous NMR chemical shift
perturbation studies have shown that binding to ICAM-1 scribed here in atomic detail, is paradigmatic of many
other cell adhesive interactions between integrins andinduced significant changes at the MIDAS and the
Recognition by an Integrin I Domain of ICAM-1
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Figure 4. Propagation of Conformational Change in the I Domain
(A–C) The effect of ligand binding (A) and remodeling of the 6-7 loop in absence of ligand binding (B and C) are compared on I domain
structures near the MIDAS (A and B) and the 7-1 interface (C). Views of (A) and (B) are similar and (C) is approximately orthogonal to (B).
Key residues in conformational change are shown in ball-and-stick and labeled, except Gly-240 is unlabeled and shown as a large C atom
sphere and MIDAS residues Ser-139 and Ser-141 are shown but not labeled. Metal ions are shown as large spheres with the same color as
the backbone of the corresponding I domain. The position of the missing metal ion in the unliganded high-affinity structure is simulated by
superimposing the metal ion from the pseudo-liganded high-affinity structure and is shown smaller than the other metals. Side chain oxygen
atoms are shown as red; water oxygens are omitted for clarity. The directions of major shifts from closed to open conformations are shown
with arrows. A portion of ICAM-1 domain-1 containing the metal-coordinating residue E34 is shown in cyan. In (C), the side chain bonds in
the designed disulfide bridge (Cys-287-Cys-294) are shown in gray.
(D) The hydrophobic pocket that acts as a detent for the rachet-like movement of the 6-7 loop. The backbone of the 6-7 loop and the
three residues that occupy the same hydrophobic pocket in the three different conformational states are shown in the same color key as in
(A)–(C). The pocket is shown as a GRASP van der Waals surface using the wild-type 1LFA structure with the residues from 287 to the C
terminus deleted. The upper hydrophobic pocket is also shown, which is occupied only in the closed conformation (by F292 which is shown
in the wild-type structure along with L295). For the closed conformation, the 6-7 main chain trace is broken between F292 and L295 for
clarity. The view is about the same as in (C). On the otherwise gray GRASP surface, residues Ile-150, Phe-153, Ile-237, Ile-259, and Ile-261
are colored yellow to show the hydrophobic pockets.
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IgSF members (Wang and Springer, 1998). The binding diate-affinity I domain is partially pulled down, whereas
that of the unliganded high-affinity I domain is markedlysite has several remarkable features. Both the shift in
displaced downward (Figures 4C and 5B). The struc-coordination at the MIDAS and the remarkable swing of
tures of the M and 2 I domains in the open and closedthe Glu-241 side chain in the 4-5 MIDAS loop appear
conformations are shown for comparison (Figure 5B;to be important in switching the I domain into a high-
Emsley et al., 1997, 2000; Lee et al., 1995a, 1995b). Theaffinity state. Our finding that Glu-241 forms a salt bridge
closed L, M, and 2 I domains share an identicalto Lys-39 of ICAM-1 demonstrates a novel mechanism
conformation of the 6-7 loop. The open 2 and M Ifor regulating LFA-1 binding to ICAM-1. This Glu residue
domain structures also have an identical conformationis highly conserved, and its swing may be a general
of the 6-7 loop, which differs markedly from themechanism for regulating ligand binding by I domains.
closed conformation of this loop. Importantly, the unli-Furthermore, the binding interface described here pro-
ganded, high-affinityL I domain mutant has an identicalvides an atomic framework for the development of an
open conformation in the 6 strand and the 6-7 loopimportant class of pharmaceutical antagonists.
(Figure 5B). It is these regions that have the importantCould the wild-type I domain bind in the closed or
interactions with the hydrophobic core that regulate theintermediate conformation to ICAM-1? Superposition on
conformation of the MIDAS. The conformation of 7 inthe cocrystal structure shows no significant clashes.
the high-affinityL mutant differs markedly, partially dueThe6-7 loop in the closed and intermediate structures
to the constraint from the engineered disulfide bond;is too far from the bound ICAM-1 to block ligand binding.
however, the conformation of 7 is highly variable, asThus, the downward movement of this loop upon I do-
shown by comparison of different L structures in themain activation has no direct role in exposing the
closed conformation (Figure 5C). Because the remainderICAM-1 binding site. In the closed conformation, the
of the high-affinity mutant I domain including the MIDASMg2 ion would be too far away for direct coordination
is in the open, ligand binding configuration, the struc-to Glu-34 of ICAM-1, but would be at an appropriate
tural comparison suggests that the conformation of distance for indirect coordination. Therefore, subse-
strand 6 and the6-7 loop, but not the structural detailsquent to ligand binding, reshaping to the open confor-
of 7 per se, are critical for the packing interactions inmation could occur, including lateral movement of the
the hydrophobic core that open the ligand binding site.1-1 backbone with readjustments of its side chains
In intact integrins, 7 helix movement would thereforethat contact ICAM-1. The shifts in MIDAS coordination
appear to be linked to ligand binding only through itsand the swing of the Glu-241 side chain toward Lys-
effect on 6-7 loop conformation.39 of ICAM-1 could be accommodated subsequent to
The 6-7 loop of the intermediate-affinity I domainICAM-1 binding. Thus, ICAM-1 could bind to an L I
is in a position intermediate between that exhibited indomain in the closed or intermediate conformation, and
the open and closed conformations of the L, M, andthen favor a shift to the open conformation.
2 I domains (Figure 5B). In the low-affinity, closed con-
formation, Phe-292 is in the top of the 6-7 loop, buriedAllosteric Regulation of Ligand Binding
in a hydrophobic pocket (Figure 4D). The removal of Phe-by the 6-7 Loop: Inside-Out Signaling
292 from this pocket is key to enabling rearrangement at
The high-affinity L I domain crystallized in unliganded
the MIDAS (Figures 4B and 4C). Furthermore, another
and pseudo-liganded forms. The two structures have
hydrophobic pocket 5.5 A˚ lower down the side of the
essentially identical open conformations, with a root domain is occupied successively by Leu-295, Phe-292,
mean square deviation of 0.57 A˚ for all C atoms. The and Leu-289 in the low-, intermediate-, and high-affinity
MIDAS residues of both structures are in the open con- structures, respectively (Figure 4D). Although the 7 he-
formation (Figures 3B and 3C); however, the unliganded lix is disrupted in the high-affinity L I domain by the
high-affinity structure lacks a metal ion at the MIDAS disulfide bond, in the 2 and M I domains the 7 helix
(Figure 3C). In the absence of a metal and a ligand, is displaced by two turns of helix down the side of the
a water molecule mediates a hydrogen bond network domain between the open and closed conformations
among Asp-137, Ser-139, and Ser-141. The absence of (Emsley et al., 2000; Lee et al., 1995a). In the closed
metal coordination and the presence of electrostatic conformation of the L I domain, residues 292–295 in
repulsion by Asp-137 cause the side chain of Asp-239 the upper part of7 form a 310 helix (Qu and Leahy, 1996).
to swing away from other MIDAS residues (Figure 3C). In the intermediate conformation of the L I domain, this
In the pseudo-liganded high-affinity I domain, the metal turn of 310 helix beginning with Phe-292 is displaced
coordination is completed by an exogenous Glu-272 downward a distance corresponding to one turn of helix,
from a crystallographic symmetry mate (Figure 3B). This and Phe-292 is deeply buried in the hydrophobic pocket
lattice contact is similar to that in the open conformation (Figure 4D). The pocket thus acts as a detent that holds
of the M I domain (Lee et al., 1995b), except that the the 6-7 loop in three different ratchet positions, and
Glu is donated by  helix 6 instead of  helix 7. The Glu each movement displaces the 7 helix a distance down-
in the ligand-mimetic lattice contact binds in a similar ward corresponding to one turn of helix (see Supplemen-
orientation to the Glu in ICAM-1 (Figures 3A and 3B). tal Movie S1 at http://www.cell.com/cgi/content/full/
The effect of inside-out signaling on I domain confor- 112/1/99/DC1).
mation is mimicked by pulling down the C-terminal 7 Comparison of the unliganded, high-affinity open
helix with disulfide bonds in the absence of ligand bind- structure and the wild-type closed structure shows that
ing (Figure 5A). In comparison to the wild-type L I do- the conformational changes induced by pulling down
main, which assumes the closed conformation (Qu and the 6-7 loop with a disulfide bridge are first propa-
gated to the hydrophobic core of the I domain and thenLeahy, 1995), the 6-7 loop of the unliganded interme-
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107
Figure 5. The Structures of the Unliganded
Wild-Type, Intermediate-Affinity, and High-
Affinity L I Domains
(A) The three unliganded L I domain back-
bones are shown superimposed and viewed
centered on the MIDAS. Regions of the back-
bones that differ structurally are labeled and
color keyed; other backbone regions are
gray. The metal ions at the MIDAS and the
atoms in disulfide-linked cysteines are shown
in the same colors as the backbone differ-
ences; the cysteine side chain bonds are yel-
low. As in Figure 4B, the position of the miss-
ing metal ion in the high-affinity structure is
simulated with a smaller sphere. 6-7 loop
and 7 are shown in gray for clarity; differ-
ences in these regions are shown in (B).
(B) The C-terminal fragments encompassing
the 6-7 loop for the three unligated L con-
formations and open and closed 2 and M
I domain structures (color keys on bottom left
and middle). The side chain bonds of Cys-
287 and Cys-294 in the designed disulfide
bridge in the high-affinity mutant are shown
in yellow; the C atom of Cys-299 in the de-
signed disulfide of the intermediate mutant is
shown as a green sphere.
(C) The C-terminal fragments encompassing
the 6-7 loop for four different wild-type L
structures in the closed conformation (color
keys on bottom right).
to the MIDAS loops. Pulling down the 6-7 loop would to open conformation (Figure 4A compared to 4B). The
conformational changes induced in unliganded struc-have exposed hydrophobic core residues on 1, 4, and
5, had there not been nearby structural rearrange- tures by downward movement of the 6-7 loop (Figure
4B) are identical in all important respects to those in-ments. To shield the hydrophobic core from solvent, 1
moves 2 A˚ inward (Figures 4B, 4C, and 5A). In the 1- duced by ligand binding to the intermediate conforma-
tion (Figure 4A), except that after ligation the 6-7 loop1 loop, the third of three residues that form MIDAS
coordinations, Ser-141, shifts 2 A˚ in backbone position, remains in the intermediate conformation as already dis-
cussed.which in effect changes the metal coordination from the
closed to the open conformation. The movement of Leu- The unliganded intermediate-affinity and wild-type
structures are well superimposable in the regions men-142 in the 1-1 loop pushes Asp-239 in the 4-5 loop
from the primary to the secondary metal coordination tioned above (Figures 4B and 5A). Therefore, pulling
down the 6-7 loop half-way between the closed andsphere (Figure 4B). Second, there are concerted down-
ward movements of the 5-6 and 4-5 loops in order open conformations does not cause significant main
chain conformational change elsewhere in the domainto fill the space left open by the 6-7 loop (Figures 4B
and 5A). The downward movement of Phe-265 in the and leaves the ligand binding site in the closed confor-
mation (see Supplemental Movie S1 at http://www.cell.5-6 loop allows the flip of the Gly-240 main chain in
the 4-5 loop. This flip positions the Glu-241 side chain com/cgi/content/full/112/1/99/DC1). However, this in-
termediate movement produces an I domain that is ener-for contact with Lys-39 of ICAM-1 as discussed above.
The 5-6 loop, which bears Phe-265, possesses high getically primed for the above mentioned structural
rearrangements. The key Phe-292 residue in the 6-7temperature factors and differs significantly among the
four structures, largely due to its prominent role in dif- loop is already removed from its hydrophobic pocket
between  strands 4 and 5 and  helix 1, and the back-fering crystal lattice contacts. However, residue Phe-
265 on this loop is well ordered, and its position appears bone of the 6-7 loop has moved outward, away from
the hydrophobic core. Therefore, the lateral movementto be related to the structural transition from the closed
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of the 1 helix, the flip of the 4-5 loop, and the down- An Intermediate Conformation for I Domains
The finding of an intermediate conformational state ofward shift of the 5-6 loop are achievable with a lower
the I domain is novel. It is intriguing that there is excellentenergetic cost, accounting for the increased affinity for
evidence for two different activation states for L2 onligand.
cell surfaces (Constantin et al., 2000; Stewart et al., 1996;Our results show that in intact integrins, downward
van Kooyk et al., 1999). Both states are active in bindingmovement of the I domain C-terminal  helix would be
to ICAM-1 in adhesion assays, whereas only one is suffi-sufficient to convey conformational movements from
ciently high affinity to detectably bind soluble ICAM-1.other domains to the I domain, providing a mechanism
The intermediate conformation of the L I domain isfor I domain activation in inside-out signaling. The down-
very well folded, and indeed the 1.3 A˚ crystal structureward movement of the6-7 loop induced here by muta-
is the highest resolution solved for an I domain to date.tionally introduced disulfide bonds mimics a downward
The 6-7 loop and upper portion of 7 are very wellpull thought to be induced in intact integrins by interac-
packed, with an average B factor of 24 A˚2 for all nonhy-tion with the neighboring  subunit I-like domain. The
drogen atoms of residues 288–296. These findings sug-idea that the C-terminal 7 helix and the following linker
gest that the intermediate conformation of the 6-7to the -propeller domain act as a “bell rope” is sup-
loop represents a discrete conformational state thatported by findings that mutations in these regions can
could exist in intact integrins, and that the intermediateeither activate or inhibit ICAM-1 binding (Alonso et al.,
conformation could represent the second active state2002; Huth et al., 2000; Lupher et al., 2001; Oxvig et al.,
of L2 that is active in cell adhesion but does not bind1999). The 2 I-like domain regulates ligand binding by
ligand with high affinity. However, we cannot rule outthe I domain instead of directly participating in ligand
the possibility that the intermediate conformation couldbinding (Lu et al., 2001), and its MIDAS has been pro-
represent a transition state during equilibration of I do-posed to interact with an acidic residue in the I domain
mains between the open and closed conformations (Shi-linker to exert the downward pull on the bell rope, which
maoka et al., 2001). A recent study with a fluorescentactivates ligand binding by the I domain (Alonso et al.,
ligand-mimetic peptide has shown that the41 integrin2002; Huth et al., 2000; Lu et al., 2001; Shimaoka et al.,
exhibits multiple affinity states on the cell surface de-2002).
pending on the activation condition (Chigaev et al.,
Our structure of the unliganded high-affinity L I do-
2001). The presence of multiple affinity states allows
main shows for the first time that the open conformation
more precise regulation of ligand binding and could be
is stable in the absence of binding to a ligand or pseudo-
essential for the physiological functions of integrins.
ligand. Since the disulfide bonds introduced here into The structures of the unliganded intermediate-affinity
isolated I domains mimic a downward pull exerted on and high-affinity L I domains suggest two discrete
the C-terminal  helix by neighboring domains in intact steps in a shape-shifting pathway by which inside-out
integrins, our findings suggest that conformational signals can activate integrins for ligand binding. The
change in I domains could precede ligand binding in finding that the affinities of other mutant I domains clus-
intact integrins. This is of considerable biological impor- ter near those of the I domains with structurally defined
tance. The on rate for ICAM-1 binding by the closed open, intermediate, and closed conformations also sug-
conformation of the I domain is slow, and the 30-fold gests that these are discrete conformational states in the
increase in kon observed for the intermediate and open shape-shifting pathway. Recent averaging of electron
conformations (Table 1) would facilitate the rapid kinet- microscopic negatively stained images of the extracellu-
ics of integrin-mediated adhesion by leukocytes in the lar domain of integrin V3 suggest that integrins adopt
bloodstream, where cellular activation can lead to integ- at least three overall conformations: highly bent, ex-
rin activation and ligand binding in less than 1 s. Our tended with a closed headpiece, and extended with
finding that the open conformation is stable in the ab- an open headpiece (Takagi et al., 2002). It will be very
sence of ligand binding is supported by studies with interesting to determine whether integrins that contain
activation-sensitive antibodies to the L and M I do- I domains also exist in multiple overall shapes and how
mains, which show that changes in I domain conforma- conformational change in I domains is linked to specific
tion occur in intact cell surface integrins upon activation structural alterations elsewhere in integrins.
in the absence of ligand binding (Diamond and Springer,
1993; Li et al., 2002; Ma et al., 2002). Experimental Procedures
Our complex structure and previous crystal studies
on M and 2 I domains (Emsley et al., 2000; Lee et al., Protein Expression and Purification
Wild-type and mutant I domains were expressed in E. coli BL21(DE3)1995b) show that ligand binding can also stabilize the
(Novagen, Madison, WI), refolded, and purified as described (Leggeopen conformation of the I domain. Thus, although it
et al., 2000; Shimaoka et al., 2001), except 0.2 mM CuSO4 and 1has often been disputed whether conformational change
mM o-phenanthroline were used to catalyze disulfide bond forma-
precedes or follows ligand binding, the findings actually tion and purification was on a monoQ HR5/5 ion-exchange column
support both concepts. Furthermore, the ligand binding (Pharmacia) and a Superdex 200 column (Pharmacia). Intramolecu-
lar disulfide bonds were confirmed in all mutants by decreasedsite of the unliganded, high-affinity L I domain has the
mobility in SDS-PAGE after reduction (Shimaoka et al., 2001).same open conformation as the liganded or pseudo-
A cDNA encoding the ICAM-1 signal sequence, residues Q1 toliganded I domains. This demonstrates that signal trans-
T291, and an additional C-terminal alanine was subcloned into pMT/
mission through the hydrophobic core of the I domain BiP/V5-His insect cell expression vector (Invitrogen). S2 insect cells
works the same in both directions, i.e., in both inside- (Invitrogen) grown in Drosophila serum-free medium (Invitrogen)
were cotransfected with 19 g pMT/BiP/V5-His containing theout and outside-in signaling.
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ICAM-1 fragment and 1 g pCoHYGRO (Invitrogen) with the calcium N-acetylglucosamine residues at each of the four N-linked glycosyl-
ation sites. The electron density for I domain residues 285–298 isphosphate method and selected with 300 g/ml hygromycin. Induc-
tion with 500 M CuSO4 for more than 16 hr yielded 1 mg/l ICAM-1. relatively poor. However, a continuous density that connects the
main chain is clearly visible at 0.7
 contour level, with the exceptionICAM-1 was purified as described (Dustin et al., 1992) and further
with monoQ ion-exchange chromatography in 20 mM Tris HCl (pH of residues 286 and 287 for both I domains. It appears that these
two residues could adopt multiple conformations. Therefore, the8) with a gradient of 0 to 1 M NaCl.
Val-286 and Lys-287 side chains are modeled with an occupancy
of 0.50 and probably represent the most stable conformation.Surface Plasmon Resonance
The pseudo-liganded high-affinity I domain with a Mn2 ion at theSoluble monomeric ICAM-1, or BSA as a negative control, was im-
MIDAS was solved using the uncomplexed intermediate-affinity Imobilized on a CM-5 sensor chip by the amine coupling method. I
domain structure as a search model. Water molecules with at leastdomains were perfused onto the chip in Tris-buffered saline solution
one hydrogen bond to protein atoms and a temperature factor belowplus 1 mM MgCl2, at a flow rate of 10 l/min, at 25	C (Shimaoka et
80 A˚2 were included.al., 2001).
The structure of the unliganded high-affinity I domain was solved
using the liganded high-affinity structure as a search model. ToCrystallization and Data Collection
minimize model bias, regions of the search model including theCrystals were grown by the hanging drop vapor diffusion method
three MIDAS loops, the 5-6 loop, and the C-terminal fragmentat room temperature. One to two microliters of protein solution (10
starting from 6 were removed during initial cycles of refinement.to 20 mg/ml) was mixed with an equal volume of well solution on a
Simulated annealing omit maps (Hodel et al., 1992) were computedsiliconized glass coverslide and equilibrated against 1 ml of the well
and inspected during model rebuilding. The identity of a water mole-solution. The intermediate-affinity I domain was crystallized with
cule instead of a metal ion at the MIDAS was confirmed by the30% PEG 4000, 0.05 M MgCl2, and 0.1 M Tris·Cl (pH 8.5). The inter- hydrogen bonding distance (2.6 A˚) as opposed to the magnesiummediate affinity I domain in complex with ICAM-1 domains 1 to 3
coordinating distance of about 2.0 A˚, and the absence of a bipyrami-was crystallized with 25% PEG-4000 and 0.1 M sodium acetate (pH
dal coordination sphere.4.6). The high-affinity I domain crystallized in two forms. A well
solution of 20% PEG 2000 monomethyl ether, 0.025 M MnCl2, and
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